Literature DB >> 17875522

Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia.

Yorifumi Satou1, Masao Matsuoka.   

Abstract

Adult T-cell leukemia (ATL) is a leukemia derived from CD4+ mature T-cells and induced by human T-cell leukemia virus type I (HTLV-I) infection. Although previous studies have revealed many aspects of its leukemogenesis, enigmas remain about how HTLV-I transforms mature T-cells in infected individuals. Furthermore, an effective therapy for ATL has not yet been established. The critical role of a nonstructural regulatory viral protein, Tax, in transformation has been established through many molecular studies, in vitro cell culture experiments, and transgenic mouse model systems. In addition, other accessory viral proteins have been implicated in ATL pathogenesis. Recent studies of a minus strand viral gene, HTLV-I bZIP factor (HBZ), suggest it plays a role in ATL leukemogenesis. In addition to viral components, genetic and epigenetic events of the host cellular genome must be considered in developing a complete picture of the transformation process. In this review, we summarize the molecular and cellular mechanisms involved in the leukemogenesis induced by HTLV-I; we consider both viral and host cellular factors and focus particularly on the viral gene HBZ.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875522     DOI: 10.1532/IJH97.07103

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  68 in total

1.  Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells.

Authors:  Mika Yoshida; Kisato Nosaka; Jun-ichirou Yasunaga; Ichiro Nishikata; Kazuhiro Morishita; Masao Matsuoka
Journal:  Blood       Date:  2003-12-04       Impact factor: 22.113

2.  Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

Authors:  J Levitskaya; A Sharipo; A Leonchiks; A Ciechanover; M G Masucci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

3.  HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.

Authors:  Jun Matsumoto; Takayuki Ohshima; Osamu Isono; Kunitada Shimotohno
Journal:  Oncogene       Date:  2005-02-03       Impact factor: 9.867

4.  Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus.

Authors:  T Hori; T Uchiyama; M Tsudo; H Umadome; H Ohno; S Fukuhara; K Kita; H Uchino
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

5.  Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.

Authors:  K Etoh; S Tamiya; K Yamaguchi; A Okayama; H Tsubouchi; T Ideta; N Mueller; K Takatsuki; M Matsuoka
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

Review 6.  HTLV-1 Tax and adult T-cell leukemia.

Authors:  Chou-Zen Giam; Kuan-Teh Jeang
Journal:  Front Biosci       Date:  2007-01-01

7.  Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.

Authors:  Hajime Hiraragi; Seung-Jae Kim; Andrew J Phipps; Micol Silic-Benussi; Vincenzo Ciminale; Lee Ratner; Patrick L Green; Michael D Lairmore
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.

Authors:  N D Collins; G C Newbound; B Albrecht; J L Beard; L Ratner; M D Lairmore
Journal:  Blood       Date:  1998-06-15       Impact factor: 22.113

9.  HBZ interacts with JunD and stimulates its transcriptional activity.

Authors:  Sabine Thébault; Jihane Basbous; Patrick Hivin; Christian Devaux; Jean-Michel Mesnard
Journal:  FEBS Lett       Date:  2004-03-26       Impact factor: 4.124

10.  Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa.

Authors:  Sara Calattini; Sébastien Alain Chevalier; Renan Duprez; Sylviane Bassot; Alain Froment; Renaud Mahieux; Antoine Gessain
Journal:  Retrovirology       Date:  2005-05-09       Impact factor: 4.602

View more
  9 in total

1.  Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.

Authors:  Marcia Bellon; Christophe Nicot
Journal:  Int J Cancer Oncol       Date:  2015-06-02

2.  The human T-lymphotropic virus type 1 tax protein inhibits nonsense-mediated mRNA decay by interacting with INT6/EIF3E and UPF1.

Authors:  Vincent Mocquet; Julia Neusiedler; Francesca Rende; David Cluet; Jean-Philippe Robin; Jean-Michel Terme; Madeleine Duc Dodon; Jürgen Wittmann; Christelle Morris; Hervé Le Hir; Vincenzo Ciminale; Pierre Jalinot
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

3.  Role of post-translational modifications of HTLV-1 Tax in NF-κB activation.

Authors:  Noula Shembade; Edward W Harhaj
Journal:  World J Biol Chem       Date:  2010-01-26

Review 4.  Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus.

Authors:  Paola Miyazato; Misaki Matsuo; Hiroo Katsuya; Yorifumi Satou
Journal:  Viruses       Date:  2016-06-16       Impact factor: 5.048

5.  Expression of miR-34a in T-Cells Infected by Human T-Lymphotropic Virus 1.

Authors:  Varun K Sharma; Vittoria Raimondi; Katia Ruggero; Cynthia A Pise-Masison; Ilaria Cavallari; Micol Silic-Benussi; Vincenzo Ciminale; Donna M D'Agostino
Journal:  Front Microbiol       Date:  2018-05-04       Impact factor: 5.640

6.  Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma.

Authors:  Yoshitaka Inoue; Shigeo Fuji; Ryuji Tanosaki; Yoshihiro Inamoto; Takashi Tanaka; Ayumu Ito; Keiji Okinaka; Saiko Kurosawa; Sung-Won Kim; Hitoshi Nakagama; Takahiro Fukuda
Journal:  Bone Marrow Transplant       Date:  2018-03-09       Impact factor: 5.483

7.  Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy.

Authors:  Hiromu Yano; Yukio Fujiwara; Hasita Horlad; Chang Pan; Keitaro Kai; Daisuke Niino; Kumiko Ohsawa; Morihiro Higashi; Kisato Nosaka; Yutaka Okuno; Jun-Ichi Tamaru; Akitake Mukasa; Masao Matsuoka; Yoshihiro Komohara
Journal:  Cancer Sci       Date:  2022-04-08       Impact factor: 6.518

8.  View and review on viral oncology research.

Authors:  Valeria Bergonzini; Cristiano Salata; Arianna Calistri; Cristina Parolin; Giorgio Palù
Journal:  Infect Agent Cancer       Date:  2010-05-24       Impact factor: 2.965

9.  Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells.

Authors:  Tetsuya Usui; Katsunori Yanagihara; Kunihiro Tsukasaki; Ken Murata; Hiroo Hasegawa; Yasuaki Yamada; Shimeru Kamihira
Journal:  Retrovirology       Date:  2008-04-22       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.